| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/29/2007 | CN101027065A Phospholipid compositions and methods for their preparation and use |
| 08/29/2007 | CN101027062A Phosphonate analogs of HIV inhibitor compounds |
| 08/29/2007 | CN101024729A Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 08/29/2007 | CN101024090A Gene transfering compound and its preparing method |
| 08/29/2007 | CN101024087A Chitosan and poly-piptide porphyrinl nano medicine carrier and its preparing and use |
| 08/29/2007 | CN101024086A Composition formed from chitosan and its derivatives and low-molecular heparin and pneparation and preparing method |
| 08/29/2007 | CN101024085A Precursor medicine for target treatment of colon cancer and preparing method |
| 08/29/2007 | CN101024084A Use of debranched starch in extrusive globurized medicine pellet |
| 08/29/2007 | CN101024082A Compounded medicine for wholely preventing and treating cardio-cerebral blood vessel diseases and use thereof |
| 08/29/2007 | CN101024079A Pneumo-streptococcal-polysaccharide adventitia jointed vaccine and preparing method |
| 08/29/2007 | CN101024076A Novel use of coccidium |
| 08/29/2007 | CN101023996A Chinese medicine for treating exogenous epidemic disease and anemopyretic cold |
| 08/29/2007 | CN101023984A Pregnant-woman breast-nursing oil |
| 08/29/2007 | CN101023978A Zhiloukang medicine for treating hemorrhoids and fistula |
| 08/29/2007 | CN101023977A Slow-released tablet floating in stomach for treating gastric disease |
| 08/29/2007 | CN101023958A Buccal tablet of Asraguluspolysacharin |
| 08/29/2007 | CN101023953A Composition for treating bronchia asthma |
| 08/29/2007 | CN101023951A Slow-released preparation containing hydrochlorothiazide and clonidine hydrochloride and its preparing method |
| 08/29/2007 | CN101023950A Allopurinol sodium sterilzed powder for injection and preparing method |
| 08/29/2007 | CN101023949A Loratadine dispersible tablets and its preparing method |
| 08/29/2007 | CN101023948A Rimonabant and cyclodextrin inclusion compound of its salt capable of being as medicine, its preparing method and medicine use |
| 08/29/2007 | CN101023943A Myricetin dispersion tablets for treating cardio-cerebral blood vessel diseases |
| 08/29/2007 | CN101023941A Docetaxel injecta and preparing method |
| 08/29/2007 | CN101023939A S(3-hydroxypropyl) L-cysteine tablet preparation and preparing method |
| 08/29/2007 | CN101023934A Method for preparing novel medicine capsule and plant capsule |
| 08/29/2007 | CN101023932A Coated granules containing ibuprofen |
| 08/29/2007 | CN101023931A Anti-cancer composition containing blood-vessel inhibitor and taxanes |
| 08/29/2007 | CN101023930A Anti-cancer composition carried with new-born blood-vessel inhibiting agent and alkalating agent |
| 08/29/2007 | CN101023929A Anti-cancer medicine composition carried with blood-vessel inhibiting agent and synergistic agent |
| 08/29/2007 | CN101023928A Slow-release injecta containing new-born blood-vessel-inhibiting agent and platinum-like compounds |
| 08/29/2007 | CN101023927A Stable eye lotion containing latanoprost as active ingredient |
| 08/29/2007 | CN101023924A Entity-tumor-resistant slow-release agent containing glucocorticoid hormone |
| 08/29/2007 | CN101023923A Anti-cancer slow-release agent containing glucocorticoid hormone |
| 08/29/2007 | CN101023922A Anti-cancer slow-release agent carried with glucocorticoid hormone and chemical therapy medicine |
| 08/29/2007 | CN101023921A Anti-cancer composition containing glucocorticoid hormone |
| 08/29/2007 | CN101023920A Entity-tumor-resistant medicine composition |
| 08/29/2007 | CN101023919A Entity-tumor-resistant slow-release agent |
| 08/29/2007 | CN101023918A Anti-cancer medicine composition carried with platinum-like compounds and glucocorticoid hormone |
| 08/29/2007 | CN101023917A Technology for preparing medicine and relative oral preparations |
| 08/29/2007 | CN100334228C Cimeric immunomodulatory compounds and methods of using the same |
| 08/29/2007 | CN100333795C Polysaccharide-based network and method for the production thereof |
| 08/29/2007 | CN100333792C Rsv基因表达疫苗 Rsv gene expression vaccine |
| 08/29/2007 | CN100333790C The pharmaceutical applications for combination of drugs with interleukin-2 |
| 08/29/2007 | CN100333723C Iontophoretic delivery of rotigotine for the treatment of parkinson's disease |
| 08/29/2007 | CN100333721C Levodopa nano preparation and its preparing method |
| 08/29/2007 | CN100333720C Compound analgesic agent |
| 08/29/2007 | CN100333717C Oral solid dosage of plus color to Rome salts |
| 08/29/2007 | CN100333715C Magnetic medicinal microball for directional breaking nerve back root and its preparing method |
| 08/29/2007 | CN100333714C Method for producing pellet and pastille |
| 08/29/2007 | CN100333712C Material gradient controlled-release administrating system and its three-dimensional printing-forming preparation method |
| 08/28/2007 | US7262291 Clostridial toxin derivatives and methods for treating pain |
| 08/28/2007 | US7262286 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 08/28/2007 | US7262221 Hydrophobic core coupled to plurality of hydrophilic moieties that form micelles in solution; encapsulate lipoproteins; atherosclerosis; cardiovascular disorders |
| 08/28/2007 | US7262219 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 08/28/2007 | US7262180 For therapy of dermatitis conditions and skin impairments such as atopic dermatitis, contact dermatitis, allergic contact dermatitis, allergic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of hands or feet, generalized exfoliative dermatitis, stasis dermatitis |
| 08/28/2007 | US7262177 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use |
| 08/28/2007 | US7262168 Compositions providing for increased IGF-I solubility |
| 08/28/2007 | US7262166 Chemically modified novel erythropoietin stimulating protein compositions and methods |
| 08/28/2007 | US7262165 Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 08/28/2007 | US7262164 Polymeric thiol-linked prodrugs employing benzyl elimination systems |
| 08/28/2007 | US7261907 Administering to an animal subject in need thereof an effective amount of a composition comprising a clathrate of aliphatic material and monoclinic sulfur, wherein the aliphatic material is encapsulated by the monoclinic sulfur |
| 08/28/2007 | US7261887 Leishmania as carriers for the delivery of proteins and peptides |
| 08/28/2007 | US7261876 Multimeric proteins for use in the treatment and detection of cell proliferative disorders |
| 08/28/2007 | US7261875 Dendritic poly (amino acid) carriers and methods of use |
| 08/28/2007 | CA2461157C Sustained release heterodisperse hydrogel systems - amorphous drugs |
| 08/28/2007 | CA2450650C Encapsulated cell therapy |
| 08/28/2007 | CA2405072C Gel compositions containing metronidazole |
| 08/28/2007 | CA2367755C Dimeric compounds and their use as inhibitors of neuraminidase |
| 08/28/2007 | CA2306334C Enteric coated microgranules for stabilizing lactic acid bacteria |
| 08/28/2007 | CA2293338C Isomer enriched conjugated linoleic acid compositions |
| 08/28/2007 | CA2264693C Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 08/24/2007 | CA2537724A1 Chitosan - sorbitan ester emulsions |
| 08/23/2007 | WO2007095286A2 AQUEOUS PHARMACEUTICAL FORMULATIONS OF ERβ SELECTIVE LIGANDS |
| 08/23/2007 | WO2007095043A2 Pharmaceutical formulations |
| 08/23/2007 | WO2007095041A2 Pharmaceutical formulations |
| 08/23/2007 | WO2007094486A1 Accelerating agent of calcium absorption |
| 08/23/2007 | WO2007094413A1 Medicinal composition for transdermal administration |
| 08/23/2007 | WO2007094385A1 Adhesive patch for external use with improved cohesive force and sustained-release characteristics |
| 08/23/2007 | WO2007094332A1 Disinfectant ointment |
| 08/23/2007 | WO2007093840A2 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 08/23/2007 | WO2007093806A1 Dissolution aids for oral peptide delivery comprising a biguanide |
| 08/23/2007 | WO2007093617A2 New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition |
| 08/23/2007 | WO2007093594A1 Coupling of polypeptides at the c-terminus |
| 08/23/2007 | WO2007093027A1 Delayed release pharmaceutical oral dosage form and method of making same |
| 08/23/2007 | WO2007022165A3 Factor xa inhibitor inclusion complex with cyclodextrin |
| 08/23/2007 | WO2007011960A3 Methods and agents to treat autoimmune diseases |
| 08/23/2007 | WO2007010552B1 N- terminal peg conjugate of erythropoietin |
| 08/23/2007 | WO2006116565A3 Biodegradable peptide sustained release compositions containing porogens |
| 08/23/2007 | WO2006094826A3 Method for coupling enzymatically activated glycoconjugates to a hydroxyalkyl starch |
| 08/23/2007 | WO2006013039A3 A process for the preparation of a piroxicam: betacyclodextrin inclusion compound |
| 08/23/2007 | WO2005123907A3 Ex-vivo application of solid microparticulate therapeutic agents |
| 08/23/2007 | WO2005107817A3 Medical device with coating for capturing genetically-altered cells and methods of using same |
| 08/23/2007 | WO2005107815A3 Polymer derivatives comprising an imide branching point |
| 08/23/2007 | WO2005069966B1 Vascular grafts with amphiphilic block copolymer coatings |
| 08/23/2007 | WO2005035003A9 Compositions and methods for increasing drug efficiency |
| 08/23/2007 | US20070199078 Single chain Fv antibody fragments; for diagnosis/prognosis of human colorectal tumors |
| 08/23/2007 | US20070197776 Hydrogels for protein concentration |
| 08/23/2007 | US20070197775 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | US20070197648 Pharmaceutical product containing tranilast |
| 08/23/2007 | US20070197644 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |